By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetic test company Genetic Technologies said on Monday that it posted A$1.5 million (US$1.6 million) in revenues for its fiscal second quarter.

The company had no reported R&D spending during the quarter ended Dec. 31, 2011. Advertising and marketing expenses came in at A$92,651.

Genetic Technologies said it had a net loss of A$2.2 million and ended the quarter with A$12.6 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.